Inherited retinal disease market forecast showing steady industry progress

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Inherited Retinal Disease Market Progress Between 2026 And 2030?

The inherited retinal disease market has seen significant expansion in recent years. It is expected to grow from $12.54 billion in 2025 to $13.6 billion in 2026, at a compound annual growth rate (CAGR) of 8.4%. This past growth can be attributed to several factors, including the identification of disease-causing retinal genes, advancements in retinal imaging technologies, increased awareness of inherited eye disorders, the expansion of specialized ophthalmology clinics, and both public and private funding for rare disease research.

The inherited retinal disease market is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $18.62 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.2%. This projected expansion during the forecast period is primarily driven by progress in gene therapy platforms, the increasing number of approvals for innovative retinal treatments, wider access to genetic screening programs, the extension of precision medicine efforts, and enhanced investment in developing treatments for rare ophthalmic conditions. Key developments expected within the forecast timeframe encompass a greater uptake of genetic testing for early detection, an intensified emphasis on gene and cell-based therapeutic strategies, the broadening of individualized treatment methods, an increase in clinical trials for uncommon retinal disorders, and enhanced patient accessibility to sophisticated retinal imaging technologies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/inherited-retinal-disease-global-market-report

Which Primary Drivers Are Impacting The Inherited Retinal Disease Market Growth?

The rising occurrence of macular degeneration is projected to drive the expansion of the inherited retinal disease market in the future. Macular degeneration, an ocular condition linked to aging, harms the macula, resulting in a loss of central vision and challenges with tasks like reading or identifying faces. The growing incidence of macular degeneration is fueled by demographic shifts towards older populations, increased life spans, and lifestyle elements like smoking and inadequate nutrition, all of which heighten the risk. Treatments for inherited retinal disease assist macular degeneration sufferers by addressing the fundamental genetic origins of retinal degeneration. These therapies aim to decelerate disease progression, recover lost vision, or even avert additional retinal damage, ultimately enhancing visual results and the overall quality of life for those afflicted by either age-related or inherited types of macular degeneration. For example, in February 2024, the Canadian Ophthalmological Society, a nonprofit organization based in Canada, reported that 2.5 million individuals in Canada over the age of 55 experience vision loss attributed to age-related macular degeneration (AMD). Consequently, the expanding prevalence of macular degeneration is fueling the growth of the inherited retinal disease market.

How Are Different Segments Classified In The Inherited Retinal Disease Market Segment Analysis?

The inherited retinal disease market covered in this report is segmented –

1) By Type: Diagnosis, Therapy

2) By Disease Type: Retinitis Pigmentosa, Choroideremia, Stargardt Disease, Cone-rod Dystrophy, Leber Congenital Amaurosis, Other Diseases

3) By Distribution Channel: Retail Sales, Direct Tender

4) By End User: Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Home Healthcare, Other End Users

Subsegments:

1) By Diagnosis: Genetic Testing, Retinal Imaging, Electrophysiological Testing (Electroretinography), Visual Field Testing, Fundus Autofluorescence Imaging

2) By Therapy: Gene Therapy, Stem Cell Therapy, Retinal Prosthesis (Artificial Retina), Pharmacological Therapy, Photoreceptor Rescue Therapy

Which Trends Are Shaping Growth In The Inherited Retinal Disease Market?

Leading companies in the inherited retinal diseases market are concentrating on developing innovative treatments, such as mutation-agnostic gene therapy, to offer inclusive therapeutic options and address the diverse genetic variations associated with these conditions. This treatment approach, mutation-agnostic gene therapy, focuses on broader genetic mechanisms or pathways rather than specific mutations, making it applicable across various genetic disorders. For example, in March 2024, Nanoscope Therapeutics Inc, a US-based biotechnology company, announced favorable results from a clinical trial for its main program, MCO-010. The trial demonstrated improvements in vision for patients experiencing permanent and severe vision loss due to advanced retinitis pigmentosa. MCO-010 successfully achieved its primary and key secondary endpoints with statistical significance and without any serious adverse events.

Who Are The Companies Driving Activity In The Inherited Retinal Disease Market?

Major companies operating in the inherited retinal disease market are Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, Endogena Therapeutics

Get The Full Inherited Retinal Disease Market Report:

https://www.thebusinessresearchcompany.com/report/inherited-retinal-disease-global-market-report

Which Region Is The Top Contributor To The Inherited Retinal Disease Market By Share?

North America was the largest region in the inherited retinal disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inherited retinal disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Inherited Retinal Disease Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/inherited-retinal-disease-global-market-report

Browse Through More Reports Similar to the Global Inherited Retinal Disease Market 2026, By The Business Research Company

Anemia And Other Blood Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Retinal Biologics Market Report 2026

https://www.thebusinessresearchcompany.com/report/retinal-biologics-global-market-report

Age Related Macular Degeneration Market Report 2026

https://www.thebusinessresearchcompany.com/report/age-related-macular-degeneration-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795